Cost-sharing mechanisms such as copays and deductibles are common features of health insurance systems worldwide. These measures aim to control costs by reducing unnecessary healthcare utilization, but they also carry significant risks. Decades of research reveal that increased cost-sharing often leads to poorer health outcomes and higher long-term costs.
The Rationale Behind Cost-SharingAt its core, cost-sharing seeks to address moral hazard—the idea that individuals may overuse healthcare services when they do not bear the full cost. By requiring patients to pay a portion of their healthcare expenses, insurers hope to encourage more judicious use of services. However, this approach can unintentionally deter patients from seeking necessary care, particularly for chronic conditions where ongoing treatment adherence is essential.
The Evidence on Copays and Health OutcomesEmpirical studies have consistently shown that higher copays lead to reduced adherence to essential medications and worse health outcomes:
A doubling of copays reduced adherence to antidiabetes medications by 23% and antihypertension medications by 10%, according to a study by Goldman et al. (2007).
Huskamp et al. (2005) found that increasing copays by $10–$20 per prescription led 21% of patients to stop taking cholesterol-lowering medications, compared to 11% in a control group.
Hsu et al. (2006) reported that higher cost-sharing was associated with worse clinical outcomes, including elevated blood pressure, increased emergency department visits, and higher mortality rates.
Wu et al. (2022) conducted a systematic review, finding that increased cost-sharing is consistently associated with worse adherence, persistence, or discontinuation of medications (Wu et al., 2022).
These findings illustrate a clear pattern: increased cost-sharing disproportionately impacts patients with chronic illnesses, where medication adherence is critical to preventing complications and hospitalizations.
The Broader ImplicationsThe impact of cost-sharing extends beyond individual health outcomes. Reduced adherence to treatment regimens can lead to greater use of emergency services, increased hospitalizations, and higher overall healthcare costs. For instance, a patient who skips antihypertensive medication due to high copays may later require expensive acute care for a stroke—a scenario that highlights the false economy of cost-sharing mechanisms.
Moreover, the burden of cost-sharing often falls disproportionately on low-income populations, exacerbating health inequities. Research by Michael Chernew and colleagues explored the effects of increased patient cost-sharing on socioeconomic disparities in healthcare. Their findings suggest that higher cost-sharing disproportionately affects individuals in low-income areas, leading to decreased adherence to essential medications and widening health inequities (Chernew et al., 2008).
Rethinking Cost-Sharing: A Systems PerspectiveGiven the evidence, policymakers and insurers must critically evaluate the role of copays and deductibles in health insurance design. Instead of applying blanket cost-sharing measures, a more nuanced approach could focus on aligning financial incentives with value-based care principles. For example:
Exemptions for Chronic Disease Management: Reducing or eliminating copays for medications and services critical to managing chronic conditions can improve adherence and reduce long-term costs.
Tiered Cost-Sharing Models: Introducing lower copays for high-value services, such as preventive care and essential medications, while maintaining higher copays for low-value interventions, can promote cost-effective utilization.
ConclusionThe evidence is clear: while cost-sharing mechanisms like copays and deductibles aim to curb healthcare spending, they often come at the expense of patient outcomes and long-term cost efficiency. Policymakers and insurers must move beyond the simplistic rationale of cost-sharing and adopt strategies informed by rigorous evidence, incorporating evidence-based exemptions and incentives.
Comments